The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D.
{iframe}http://fortune.com/2018/02/16/roche-flatiron-health-deal-why-it-matters/{/iframe}